# Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation

> **NCT02554903** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 57 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Macitentan 10mg
- **DRUG:** Placebo sugar pill

## Key facts

- **NCT ID:** NCT02554903
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-28
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554903, "Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02554903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*